Morgan Stanley downgrades Cipla Ltd
The bank adds that the drugmaker's move to build a marketing and sales front-end operation in the United States and Europe will yield results only in the longer term.
Also read:Cipla Q1 net profit jump 10%, revenue rise by 19%
Morgan Stanley's downgrade comes a day after Macquarie upgraded Cipla to "outperform" from "neutral", saying the drugmaker's April-June earnings were "significantly above" their estimates.
Cipla on Saturday posted an 18.5 percent jump in April-June net profit to 4.75 billion rupees.
Cipla shares are up 1.8 percent at 12.14 p.m.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.